{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T01:30:40Z","timestamp":1777944640766,"version":"3.51.4"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T00:00:00Z","timestamp":1777680000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T00:00:00Z","timestamp":1777680000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Natural Science Foundation of Xinjiang","award":["2025D01C440"],"award-info":[{"award-number":["2025D01C440"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-11874-z","type":"journal-article","created":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T08:12:42Z","timestamp":1777709562000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Emerging roles for SNRPB2 in governing the cell cycle and steering tumor immune modulation in breast cancer"],"prefix":"10.1007","volume":"53","author":[{"given":"Jiazhennan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yizhen","family":"Jia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adalaiti","family":"Yasheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoye","family":"Ai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiuli","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,5,2]]},"reference":[{"key":"11874_CR1","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1038\/s41591-025-03502-3","volume":"31","author":"J Kim","year":"2025","unstructured":"Kim J, Harper A, McCormack V et al (2025) Global patterns and trends in breast cancer incidence and mortality across 185 countries. Nat Med 31:1154\u20131162. https:\/\/doi.org\/10.1038\/s41591-025-03502-3","journal-title":"Nat Med"},{"key":"11874_CR2","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.jncc.2025.02.002","volume":"5","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Ji Y, Liu S et al (2025) Global burden of female breast cancer: new estimates in 2022, temporal trend and future projections up to 2050 based on the latest release from GLOBOCAN. J Natl Cancer Cent 5:287\u2013296. https:\/\/doi.org\/10.1016\/j.jncc.2025.02.002","journal-title":"J Natl Cancer Cent"},{"key":"11874_CR3","doi-asserted-by":"publisher","first-page":"C343","DOI":"10.1152\/ajpcell.00109.2021","volume":"321","author":"KM Turner","year":"2021","unstructured":"Turner KM, Yeo SK, Holm TM et al (2021) Heterogeneity within molecular subtypes of breast cancer. Am J Physiol Cell Physiol 321:C343\u2013C354. https:\/\/doi.org\/10.1152\/ajpcell.00109.2021","journal-title":"Am J Physiol Cell Physiol"},{"key":"11874_CR4","doi-asserted-by":"publisher","first-page":"265","DOI":"10.2147\/BCTT.S516542","volume":"17","author":"H Jie","year":"2025","unstructured":"Jie H, Ma W, Huang C (2025) Diagnosis, prognosis, and treatment of triple-negative breast cancer: A review. Breast Cancer (Dove Med Press) 17:265\u2013274. https:\/\/doi.org\/10.2147\/BCTT.S516542","journal-title":"Breast Cancer (Dove Med Press)"},{"key":"11874_CR5","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/s00404-025-08028-0","volume":"312","author":"N Tauber","year":"2025","unstructured":"Tauber N, Amann N, Dannehl D et al (2025) Therapy of early breast cancer: current status and perspectives. Arch Gynecol Obstet 312:311\u2013328. https:\/\/doi.org\/10.1007\/s00404-025-08028-0","journal-title":"Arch Gynecol Obstet"},{"key":"11874_CR6","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/s41392-024-02108-4","volume":"10","author":"X Xiong","year":"2025","unstructured":"Xiong X, Zheng LW, Ding Y et al (2025) Breast cancer: pathogenesis and treatments. Signal Transduct Target Ther 10:49. https:\/\/doi.org\/10.1038\/s41392-024-02108-4","journal-title":"Signal Transduct Target Ther"},{"key":"11874_CR7","doi-asserted-by":"publisher","first-page":"1405491","DOI":"10.3389\/fonc.2024.1405491","volume":"14","author":"N Xiong","year":"2024","unstructured":"Xiong N, Wu H, Yu Z (2024) Advancements and challenges in triple-negative breast cancer: a comprehensive review of therapeutic and diagnostic strategies. Front Oncol 14:1405491. https:\/\/doi.org\/10.3389\/fonc.2024.1405491","journal-title":"Front Oncol"},{"key":"11874_CR8","doi-asserted-by":"publisher","first-page":"359","DOI":"10.2340\/1651-226X.2024.33008","volume":"63","author":"M Otterlei Fjortoft","year":"2024","unstructured":"Otterlei Fjortoft M, Huse K, Rye IH (2024) The tumor immune microenvironment in breast cancer progression. Acta Oncol 63:359\u2013367. https:\/\/doi.org\/10.2340\/1651-226X.2024.33008","journal-title":"Acta Oncol"},{"key":"11874_CR9","doi-asserted-by":"publisher","first-page":"610303","DOI":"10.3389\/fonc.2021.610303","volume":"11","author":"V Salemme","year":"2021","unstructured":"Salemme V, Centonze G, Cavallo F et al (2021) The crosstalk between tumor cells and the immune microenvironment in breast cancer: Implications for immunotherapy. Front Oncol 11:610303. https:\/\/doi.org\/10.3389\/fonc.2021.610303","journal-title":"Front Oncol"},{"key":"11874_CR10","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1158\/2326-6066.CIR-19-0786","volume":"8","author":"CR Del Gil","year":"2020","unstructured":"Del Gil CR, Aleckovic M, Polyak K (2020) Immune escape during breast tumor progression. Cancer immunol Res 8:422\u2013427. https:\/\/doi.org\/10.1158\/2326-6066.CIR-19-0786","journal-title":"Cancer Immunol Res"},{"key":"11874_CR11","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1007\/s12672-025-03192-w","volume":"16","author":"J Guo","year":"2025","unstructured":"Guo J, Li L, Wang H et al (2025) Small nuclear ribonucleoprotein polypeptide B2 regulated by SNHG4\/miR-204-5p axis inhibits ferroptosis to aggravate the progression of hepatocellular carcinoma. Discov Oncol 16:1349. https:\/\/doi.org\/10.1007\/s12672-025-03192-w","journal-title":"Discov Oncol"},{"key":"11874_CR12","doi-asserted-by":"publisher","first-page":"1536473","DOI":"10.3389\/fonc.2025.1536473","volume":"15","author":"J Bao","year":"2025","unstructured":"Bao J, Tian X, Pan Y et al (2025) SNRPB2: a prognostic biomarker and oncogenic driver in esophageal cancer via beta-catenin\/c-Myc signaling. Front Oncol 15:1536473. https:\/\/doi.org\/10.3389\/fonc.2025.1536473","journal-title":"Front Oncol"},{"key":"11874_CR13","doi-asserted-by":"publisher","first-page":"3915","DOI":"10.1111\/cas.16356","volume":"115","author":"S Yu","year":"2024","unstructured":"Yu S, Si Y, Yu J et al (2024) SNRPB2 promotes triple-negative breast cancer progression by controlling alternative splicing of MDM4 pre-mRNA. Cancer Sci 115:3915\u20133927. https:\/\/doi.org\/10.1111\/cas.16356","journal-title":"Cancer Sci"},{"key":"11874_CR14","doi-asserted-by":"publisher","first-page":"111445","DOI":"10.1016\/j.cellsig.2024.111445","volume":"124","author":"B Li","year":"2024","unstructured":"Li B, Liu J, Huang L et al (2024) SNRPB2 in the pan-cancer landscape: A bioinformatics exploration and validation in hepatocellular carcinoma. Cell Signal 124:111445. https:\/\/doi.org\/10.1016\/j.cellsig.2024.111445","journal-title":"Cell Signal"},{"key":"11874_CR15","doi-asserted-by":"publisher","first-page":"1610721","DOI":"10.3389\/fimmu.2025.1610721","volume":"16","author":"F Xu","year":"2025","unstructured":"Xu F, Zhu CC, Lu C et al (2025) SNRPB2 facilitates esophageal squamous cell carcinoma oncogenesis and progression via E2F4 stabilization. Front Immunol 16:1610721. https:\/\/doi.org\/10.3389\/fimmu.2025.1610721","journal-title":"Front Immunol"},{"key":"11874_CR16","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1038\/s41587-019-0201-4","volume":"37","author":"D Kim","year":"2019","unstructured":"Kim D, Paggi JM, Park C et al (2019) Graph-based genome alignment and genotyping with HISAT2 and HISAT-genotype. Nat Biotechnol 37:907\u2013915. https:\/\/doi.org\/10.1038\/s41587-019-0201-4","journal-title":"Nat Biotechnol"},{"key":"11874_CR17","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S (2014) Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol 15:550. https:\/\/doi.org\/10.1186\/s13059-014-0550-8","journal-title":"Genome Biol"},{"key":"11874_CR18","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1016\/j.bbagrm.2017.07.004","volume":"1860","author":"H Xia","year":"2017","unstructured":"Xia H, Chen D, Wu Q et al (2017) CELF1 preferentially binds to exon-intron boundary and regulates alternative splicing in HeLa cells. Biochim Biophys Acta Gene Regul Mech 1860:911\u2013921. https:\/\/doi.org\/10.1016\/j.bbagrm.2017.07.004","journal-title":"Biochim Biophys Acta Gene Regul Mech"},{"key":"11874_CR19","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1093\/bib\/bbs017","volume":"14","author":"H Thorvaldsdottir","year":"2013","unstructured":"Thorvaldsdottir H, Robinson JT, Mesirov JP (2013) Integrative Genomics Viewer (IGV): high-performance genomics data visualization and exploration. Brief Bioinform 14:178\u2013192. https:\/\/doi.org\/10.1093\/bib\/bbs017","journal-title":"Brief Bioinform"},{"key":"11874_CR20","doi-asserted-by":"publisher","first-page":"D1196","DOI":"10.1093\/nar\/gkac955","volume":"51","author":"S Wu","year":"2023","unstructured":"Wu S, Huang Y, Zhang M et al (2023) ASCancer Atlas: a comprehensive knowledgebase of alternative splicing in human cancers. Nucleic Acids Res 51:D1196\u2013D1204. https:\/\/doi.org\/10.1093\/nar\/gkac955","journal-title":"Nucleic Acids Res"},{"key":"11874_CR21","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.neo.2022.01.001","volume":"25","author":"DS Chandrashekar","year":"2022","unstructured":"Chandrashekar DS, Karthikeyan SK, Korla PK et al (2022) UALCAN: An update to the integrated cancer data analysis platform. Neoplasia 25:18\u201327. https:\/\/doi.org\/10.1016\/j.neo.2022.01.001","journal-title":"Neoplasia"},{"key":"11874_CR22","doi-asserted-by":"publisher","first-page":"4101","DOI":"10.1016\/j.csbj.2021.07.014","volume":"19","author":"B Gyorffy","year":"2021","unstructured":"Gyorffy B (2021) Survival analysis across the entire transcriptome identifies biomarkers with the highest prognostic power in breast cancer. Comput Struct Biotechnol J 19:4101\u20134109. https:\/\/doi.org\/10.1016\/j.csbj.2021.07.014","journal-title":"Comput Struct Biotechnol J"},{"key":"11874_CR23","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1038\/s41588-021-00911-1","volume":"53","author":"SZ Wu","year":"2021","unstructured":"Wu SZ, Al-Eryani G, Roden DL et al (2021) A single-cell and spatially resolved atlas of human breast cancers. Nat Genet 53:1334\u20131347. https:\/\/doi.org\/10.1038\/s41588-021-00911-1","journal-title":"Nat Genet"},{"key":"11874_CR24","doi-asserted-by":"publisher","first-page":"D1526","DOI":"10.1093\/nar\/gkae1100","volume":"53","author":"C Huang","year":"2025","unstructured":"Huang C, Liu Z, Guo Y et al (2025) scCancerExplorer: a comprehensive database for interactively exploring single-cell multi-omics data of human pan-cancer. Nucleic Acids Res 53:D1526\u2013D1535. https:\/\/doi.org\/10.1093\/nar\/gkae1100","journal-title":"Nucleic Acids Res"},{"key":"11874_CR25","doi-asserted-by":"publisher","first-page":"W509","DOI":"10.1093\/nar\/gkaa407","volume":"48","author":"T Li","year":"2020","unstructured":"Li T, Fu J, Zeng Z et al (2020) TIMER2.0 for analysis of tumor-infiltrating immune cells. Nucleic Acids Res 48:W509\u2013W514. https:\/\/doi.org\/10.1093\/nar\/gkaa407","journal-title":"Nucleic Acids Res"},{"key":"11874_CR26","doi-asserted-by":"publisher","first-page":"881","DOI":"10.21037\/tcr-24-1291","volume":"14","author":"Y Jing","year":"2025","unstructured":"Jing Y, Wang Y, Li Y et al (2025) Diagnostics and immunological function of CENPN in human tumors: from pan-cancer analysis to validation in breast cancer. Transl Cancer Res 14:881\u2013906. https:\/\/doi.org\/10.21037\/tcr-24-1291","journal-title":"Transl Cancer Res"},{"key":"11874_CR27","doi-asserted-by":"publisher","first-page":"1667589","DOI":"10.3389\/fonc.2025.1667589","volume":"15","author":"J Wang","year":"2025","unstructured":"Wang J, Wang Y, Ma H et al (2025) CLIC6\u2019s role in cancer: from broad analysis to breast cancer validation. Front Oncol 15:1667589. https:\/\/doi.org\/10.3389\/fonc.2025.1667589","journal-title":"Front Oncol"},{"key":"11874_CR28","doi-asserted-by":"publisher","first-page":"1670526","DOI":"10.3389\/fonc.2025.1670526","volume":"15","author":"D Elihamu","year":"2025","unstructured":"Elihamu D, Li Y, Wang Y et al (2025) CORO1A: a pan-cancer prognosis, diagnostic and immune biomarker based on breast cancer validation. Front Oncol 15:1670526. https:\/\/doi.org\/10.3389\/fonc.2025.1670526","journal-title":"Front Oncol"},{"key":"11874_CR29","doi-asserted-by":"publisher","first-page":"755","DOI":"10.2147\/BCTT.S537429","volume":"17","author":"X Aimaiti","year":"2025","unstructured":"Aimaiti X, Wang Y, Ismtula D et al (2025) Bystin is a prognosis and immune biomarker: From pan-cancer analysis to validation in breast cancer. Breast Cancer (Dove Med Press) 17:755\u2013779. https:\/\/doi.org\/10.2147\/BCTT.S537429","journal-title":"Breast Cancer (Dove Med Press)"},{"key":"11874_CR30","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/j.ccell.2021.03.010","volume":"39","author":"JM Suski","year":"2021","unstructured":"Suski JM, Braun M, Strmiska V et al (2021) Targeting cell-cycle machinery in cancer. Cancer Cell 39:759\u2013778. https:\/\/doi.org\/10.1016\/j.ccell.2021.03.010","journal-title":"Cancer Cell"},{"key":"11874_CR31","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1093\/jmcb\/mjz033","volume":"11","author":"Q Yang","year":"2019","unstructured":"Yang Q, Zhao J, Zhang W et al (2019) Aberrant alternative splicing in breast cancer. J Mol Cell Biol 11:920\u2013929. https:\/\/doi.org\/10.1093\/jmcb\/mjz033","journal-title":"J Mol Cell Biol"},{"key":"11874_CR32","doi-asserted-by":"publisher","unstructured":"Oh J, Pradella D, Shao C et al (2021) Widespread alternative splicing changes in metastatic breast cancer cells. Cells 10. https:\/\/doi.org\/10.3390\/cells10040858","DOI":"10.3390\/cells10040858"},{"key":"11874_CR33","doi-asserted-by":"publisher","first-page":"604262","DOI":"10.3389\/fgene.2020.604262","volume":"11","author":"S Wu","year":"2020","unstructured":"Wu S, Wang J, Zhu X et al (2020) The functional impact of alternative splicing on the survival prognosis of triple-negative breast cancer. Front Genet 11:604262. https:\/\/doi.org\/10.3389\/fgene.2020.604262","journal-title":"Front Genet"},{"key":"11874_CR34","doi-asserted-by":"publisher","unstructured":"Caizzi L, Monteiro-Martins S, Schwalb B et al (2021) Efficient RNA polymerase II pause release requires U2 snRNP function. Mol Cell 81:1920\u20131934 e1929. https:\/\/doi.org\/10.1016\/j.molcel.2021.02.016","DOI":"10.1016\/j.molcel.2021.02.016"},{"key":"11874_CR35","doi-asserted-by":"publisher","first-page":"775","DOI":"10.3892\/ijo.2019.4856","volume":"55","author":"S Zhang","year":"2019","unstructured":"Zhang S, Mo Q, Wang X (2019) Oncological role of HMGA2 (Review). Int J Oncol 55:775\u2013788. https:\/\/doi.org\/10.3892\/ijo.2019.4856","journal-title":"Int J Oncol"},{"key":"11874_CR36","doi-asserted-by":"publisher","unstructured":"Mansoori B, Mohammadi A, Ditzel HJ et al (2021) HMGA2 as a critical regulator in cancer development. Genes (Basel) 12. https:\/\/doi.org\/10.3390\/genes12020269","DOI":"10.3390\/genes12020269"},{"key":"11874_CR37","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1080\/14728222.2020.1736559","volume":"24","author":"B Mansoori","year":"2020","unstructured":"Mansoori B, Duijf PHG, Mohammadi A et al (2020) Overexpression of HMGA2 in breast cancer promotes cell proliferation, migration, invasion and stemness. Expert Opin Ther Targets 24:255\u2013265. https:\/\/doi.org\/10.1080\/14728222.2020.1736559","journal-title":"Expert Opin Ther Targets"},{"key":"11874_CR38","doi-asserted-by":"publisher","unstructured":"Mansoori B, Terp MG, Mohammadi A et al (2021) HMGA2 supports cancer hallmarks in triple-negative breast cancer. Cancers (Basel) 13. https:\/\/doi.org\/10.3390\/cancers13205197","DOI":"10.3390\/cancers13205197"},{"key":"11874_CR39","doi-asserted-by":"publisher","first-page":"3349","DOI":"10.1007\/s00262-023-03496-2","volume":"72","author":"MDM Maldonado","year":"2023","unstructured":"Maldonado MDM, Schlom J, Hamilton DH (2023) Blockade of tumor-derived colony-stimulating factor 1 (CSF1) promotes an immune-permissive tumor microenvironment. Cancer Immunol Immunother 72:3349\u20133362. https:\/\/doi.org\/10.1007\/s00262-023-03496-2","journal-title":"Cancer Immunol Immunother"},{"key":"11874_CR40","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1093\/intimm\/dxaa078","volume":"33","author":"T Hirano","year":"2021","unstructured":"Hirano T (2021) IL-6 in inflammation, autoimmunity and cancer. Int Immunol 33:127\u2013148. https:\/\/doi.org\/10.1093\/intimm\/dxaa078","journal-title":"Int Immunol"},{"key":"11874_CR41","doi-asserted-by":"publisher","first-page":"571","DOI":"10.7150\/jca.47022","volume":"12","author":"S Rivas-Fuentes","year":"2021","unstructured":"Rivas-Fuentes S, Salgado-Aguayo A, Arratia-Quijada J et al (2021) Regulation and biological functions of the CX3CL1-CX3CR1 axis and its relevance in solid cancer: A mini-review. J Cancer 12:571\u2013583. https:\/\/doi.org\/10.7150\/jca.47022","journal-title":"J Cancer"},{"key":"11874_CR42","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/s12282-024-01654-7","volume":"32","author":"R Guo","year":"2025","unstructured":"Guo R, Wang P (2025) The complex role of regulatory cells in breast cancer: implication for immunopathogenesis and immunotherapy. Breast Cancer 32:227\u2013241. https:\/\/doi.org\/10.1007\/s12282-024-01654-7","journal-title":"Breast Cancer"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-11874-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-11874-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-11874-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T08:12:43Z","timestamp":1777709563000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-11874-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,2]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["11874"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-11874-z","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,2]]},"assertion":[{"value":"9 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The authors declare that they have no conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"705"}}